Search

Displaying results 6761 - 6770 of 9322 in total
  1. Drug

    Rupintrivir

    go.drugbank.com/drugs/DB05102
    Experimental

    It is designed to combat colds caused by rhinovirus.

  2. Drug

    TM5614

    go.drugbank.com/drugs/DB16516
    Investigational

    TM5614 inhibition of PAI-1, specifically, downregulates PCSK9 at the transcriptional level[A228793].

  3. Drug

    Felezonexor

    go.drugbank.com/drugs/DB21067
    Investigational

    The usage of the INN stem '-nexor' in the name indicates that Felezonexor is a nuclear export inhibitor.

  4. Drug

    Edaxeterkib

    go.drugbank.com/drugs/DB21490
    Investigational

    The usage of the INN stem '-terkib' in the name indicates that Edaxeterkib is a extracellular signal-regulated kinase (ERK) inhibitor.

  5. Drug

    Telenzepine

    go.drugbank.com/drugs/DB19508
    Investigational

    The usage of the INN stem '-zepine' in the name indicates that Telenzepine is a tricyclic compound.

  6. Drug

    Ledaborbactam etzadroxil

    go.drugbank.com/drugs/DB21455
    Investigational

    The usage of the INN stem '-bactam' in the name indicates that Ledaborbactam etzadroxil is a ẞ-lactamase inhibitor.

  7. Drug

    Icovamenib

    go.drugbank.com/drugs/DB21669
    Investigational

    The usage of the INN stem '-menib' in the name indicates that Icovamenib is a menin interaction inhibitor.

  8. Drug

    REC-994

    go.drugbank.com/drugs/DB15616
    Investigational

    REC-994 was cleared by the FDA in July, 2018 for a phase I trial for the treatment of cerebral cavernous malformation (CCM).

  9. Drug

    ATA-100

    go.drugbank.com/drugs/DB18329
    Investigational

    ATA-100 is an adeno-associated virus serotype 9 carrying the human Fukutin-Related protein gene and target sequence of the miR-208a

  10. Drug

    MDX-1379

    go.drugbank.com/drugs/DB05329
    Investigational

    This drug is underinvestigation to treat malignant melanoma.